These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 15265950

  • 1. Type I IFN protects against murine lupus.
    Hron JD, Peng SL.
    J Immunol; 2004 Aug 01; 173(3):2134-42. PubMed ID: 15265950
    [Abstract] [Full Text] [Related]

  • 2. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR.
    J Immunol; 1998 Jul 01; 161(1):494-503. PubMed ID: 9647261
    [Abstract] [Full Text] [Related]

  • 3. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E, Lenda DM, Kelley VR.
    J Immunol; 2003 Apr 01; 170(7):3915-25. PubMed ID: 12646661
    [Abstract] [Full Text] [Related]

  • 4. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

  • 5. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
    Feeney AJ, Lawson BR, Kono DH, Theofilopoulos AN.
    J Immunol; 2001 Sep 15; 167(6):3486-93. PubMed ID: 11544342
    [Abstract] [Full Text] [Related]

  • 6. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM, Stanley ER, Kelley VR.
    J Immunol; 2004 Oct 01; 173(7):4744-54. PubMed ID: 15383612
    [Abstract] [Full Text] [Related]

  • 7. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.
    Hadj-Slimane R, Chelbi-Alix MK, Tovey MG, Bobé P.
    J Interferon Cytokine Res; 2004 Dec 01; 24(12):717-28. PubMed ID: 15684739
    [Abstract] [Full Text] [Related]

  • 8. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T, Sugiyama N, Niiro H, Harada M.
    Arthritis Rheum; 2007 May 01; 56(5):1618-28. PubMed ID: 17469144
    [Abstract] [Full Text] [Related]

  • 9. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease.
    Bossù P, Neumann D, Del Giudice E, Ciaramella A, Gloaguen I, Fantuzzi G, Dinarello CA, Di Carlo E, Musiani P, Meroni PL, Caselli G, Ruggiero P, Boraschi D.
    Proc Natl Acad Sci U S A; 2003 Nov 25; 100(24):14181-6. PubMed ID: 14615579
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Exacerbated autoimmunity in the absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1.
    Nickerson KM, Cullen JL, Kashgarian M, Shlomchik MJ.
    J Immunol; 2013 Apr 15; 190(8):3889-94. PubMed ID: 23467932
    [Abstract] [Full Text] [Related]

  • 12. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
    Takahashi T, Yagi T, Kakinuma S, Kurokawa A, Okada T, Takatsu K, Aizawa S, Katagiri T.
    J Immunol; 1997 Sep 01; 159(5):2532-41. PubMed ID: 9278347
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
    Schwarting A, Moore K, Wada T, Tesch G, Yoon HJ, Kelley VR.
    J Immunol; 1998 Apr 15; 160(8):4074-81. PubMed ID: 9558118
    [Abstract] [Full Text] [Related]

  • 16. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
    Liang B, Kashgarian MJ, Sharpe AH, Mamula MJ.
    J Immunol; 2000 Sep 15; 165(6):3436-43. PubMed ID: 10975864
    [Abstract] [Full Text] [Related]

  • 17. Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice.
    Bökers S, Urbat A, Daniel C, Amann K, Smith KG, Espéli M, Nitschke L.
    J Immunol; 2014 Apr 01; 192(7):2994-3002. PubMed ID: 24600033
    [Abstract] [Full Text] [Related]

  • 18. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T, Ono M, Qu WM, Zhang MC, Mori S, Nakatsuru S, Nakamura Y, Sawasaki T, Endo Y, Nose M.
    Eur J Immunol; 2005 May 01; 35(5):1510-20. PubMed ID: 15832294
    [Abstract] [Full Text] [Related]

  • 19. Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain.
    Neumann D, Del Giudice E, Ciaramella A, Boraschi D, Bossù P.
    J Immunol; 2001 Mar 15; 166(6):3757-62. PubMed ID: 11238617
    [Abstract] [Full Text] [Related]

  • 20. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
    Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS.
    Kidney Int; 2004 Jan 15; 65(1):129-38. PubMed ID: 14675043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.